{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T11:28:19Z","timestamp":1768822099294,"version":"3.49.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2013,4,2]],"date-time":"2013-04-02T00:00:00Z","timestamp":1364860800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Toxicol"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1007\/s00204-013-1040-6","type":"journal-article","created":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T07:59:23Z","timestamp":1364803163000},"page":"1809-1820","source":"Crossref","is-referenced-by-count":52,"title":["The metabolic profile of mitoxantrone and its relation with mitoxantrone-induced cardiotoxicity"],"prefix":"10.1007","volume":"87","author":[{"given":"Luciana Grazziotin","family":"Rossato","sequence":"first","affiliation":[]},{"given":"Vera Marisa","family":"Costa","sequence":"additional","affiliation":[]},{"given":"Paula Guedes","family":"de Pinho","sequence":"additional","affiliation":[]},{"given":"Marcelo Dutra","family":"Arbo","sequence":"additional","affiliation":[]},{"given":"Victor","family":"de Freitas","sequence":"additional","affiliation":[]},{"given":"Laure","family":"Vilain","sequence":"additional","affiliation":[]},{"given":"Maria","family":"de Lourdes Bastos","sequence":"additional","affiliation":[]},{"given":"Carlos","family":"Palmeira","sequence":"additional","affiliation":[]},{"given":"Fernando","family":"Remi\u00e3o","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2013,4,2]]},"reference":[{"issue":"3","key":"1040_CR1","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.jpba.2009.09.027","volume":"51","author":"G An","year":"2010","unstructured":"An G, Morris ME (2010) HPLC analysis of mitoxantrone in mouse plasma and tissues: application in a pharmacokinetic study. J Pharm Biomed Anal 51(3):750\u2013753","journal-title":"J Pharm Biomed Anal"},{"key":"1040_CR2","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1191\/1352458503ms896oa","volume":"9","author":"JR Avasarala","year":"2003","unstructured":"Avasarala JR et al (2003) Rapid onset mitoxantrone-induced cardiotoxicity in secondary progressive multiple sclerosis. Mult Scler 9:59\u201362","journal-title":"Mult Scler"},{"key":"1040_CR3","first-page":"45","volume":"1","author":"J Basra","year":"1985","unstructured":"Basra J et al (1985) Evidence for human liver mediated-free radical formation by doxorubicin and mitozantrone. Anticancer Drug Des 1:45\u201352","journal-title":"Anticancer Drug Des"},{"key":"1040_CR4","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3109\/03602538608998294","volume":"17","author":"VK Batra","year":"1986","unstructured":"Batra VK et al (1986) Pharmacokinetics of mitoxantrone in man and laboratory animals. Drug Metab Rev 17:311\u2013329","journal-title":"Drug Metab Rev"},{"issue":"5","key":"1040_CR5","first-page":"871","volume":"19","author":"J Blanz","year":"1991","unstructured":"Blanz J et al (1991) Evidence for oxidative activation of mitoxantrone in human, pig, and rat. Drug Metab Dispos 19(5):871\u2013880","journal-title":"Drug Metab Dispos"},{"issue":"3","key":"1040_CR6","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0041-008X(03)00128-5","volume":"189","author":"EF Brandon","year":"2003","unstructured":"Brandon EF et al (2003) An update on in vitro test methods in human hepatic drug biotransformation research: pros and cons. Toxicol Appl Pharmacol 189(3):233\u2013246","journal-title":"Toxicol Appl Pharmacol"},{"issue":"2","key":"1040_CR7","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.biochi.2010.09.015","volume":"93","author":"TB Br\u00fcck","year":"2011","unstructured":"Br\u00fcck TB, Br\u00fcck DW (2011) Oxidative metabolism of the anti-cancer agent mitoxantrone by horseradish, lacto-and lignin peroxidase. Biochimie 93(2):217\u2013226","journal-title":"Biochimie"},{"key":"1040_CR8","first-page":"53","volume":"8","author":"J Butler","year":"1987","unstructured":"Butler J, Hoey BM (1987) Are reduced quinones necessarily involved in the antitumour activity of quinone drugs? Br J Cancer 8:53\u201359","journal-title":"Br J Cancer"},{"issue":"20","key":"1040_CR9","first-page":"4850","volume":"53","author":"P Canal","year":"1993","unstructured":"Canal P et al (1993) Plasma and cellular pharmacokinetics of mitoxantrone in high-dose chemotherapeutic regimen for refractory lymphomas. Cancer Res 53(20):4850\u20134854","journal-title":"Cancer Res"},{"issue":"4","key":"1040_CR10","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/bjc.1989.314","volume":"60","author":"SJ Duthie","year":"1989","unstructured":"Duthie SJ, Grant MH (1989) The role of reductive and oxidative metabolism in the toxicity of mitoxantrone, adriamycin and menadione in human liver derived Hep G2 hepatoma cells. Br J Cancer 60(4):566\u2013571","journal-title":"Br J Cancer"},{"issue":"5","key":"1040_CR11","doi-asserted-by":"crossref","first-page":"365","DOI":"10.2165\/00003088-199018050-00003","volume":"18","author":"G Ehninger","year":"1990","unstructured":"Ehninger G et al (1990) Pharmacokinetics and metabolism of mitoxantrone. A review. Clin Pharmacokinet 18(5):365\u2013380","journal-title":"Clin Pharmacokinet"},{"issue":"6","key":"1040_CR12","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.1016\/S0006-3495(97)78357-7","volume":"73","author":"A Feofanov","year":"1997","unstructured":"Feofanov A et al (1997) Quantitative confocal spectral imaging analysis of mitoxantrone within living K562 cells: intracellular accumulation and distribution of monomers, aggregates, naphtoquinoxaline metabolite, and drug-target complexes. Biophys J 73(6):3328\u20133336","journal-title":"Biophys J"},{"issue":"6","key":"1040_CR13","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/BF00685596","volume":"30","author":"GR Fisher","year":"1992","unstructured":"Fisher GR, Patterson LH (1992) Lack of involvement of reactive oxygen in the cytotoxicity of mitoxantrone, CI941 and ametantrone in MCF-7 cells: comparison with doxorubicin. Cancer Chemother Pharmacol 30(6):451\u2013458","journal-title":"Cancer Chemother Pharmacol"},{"key":"1040_CR14","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0009-2797(93)90088-G","volume":"88","author":"G Fisher","year":"1993","unstructured":"Fisher G, Patterson LH, Gutierrez PL (1993) A comparison of free radical formation by quinone anti-tumour agents in MCF-7 cells and the role of NAD(P)H (quinone-acceptor) oxidoreductase (DT-diaphorase). Chem Biol Interact 88:137\u2013153","journal-title":"Chem Biol Interact"},{"issue":"2","key":"1040_CR15","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.bmc.2007.10.012","volume":"16","author":"L-W Hsin","year":"2008","unstructured":"Hsin L-W et al (2008) Synthesis, DNA binding, and cytotoxicity of 1,4-bis(2-amino-ethylamino)anthraquinone-amino acid conjugates. Bioorg Med Chem 16(2):1006\u20131014","journal-title":"Bioorg Med Chem"},{"issue":"8","key":"1040_CR16","doi-asserted-by":"crossref","first-page":"822","DOI":"10.2174\/138920007782798207","volume":"8","author":"L Jia","year":"2007","unstructured":"Jia L, Liu X (2007) The conduct of drug metabolism studies considered good practice (II): in vitro experiments. Curr Drug Metab 8(8):822\u2013829","journal-title":"Curr Drug Metab"},{"issue":"6","key":"1040_CR17","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1042\/BSR20090119","volume":"30","author":"SN Khan","year":"2010","unstructured":"Khan SN et al (2010) Effect of mitoxantrone on proliferation dynamics and cell cycle progression. Biosci Rep 30(6):375\u2013381","journal-title":"Biosci Rep"},{"issue":"1\u20132","key":"1040_CR18","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.canlet.2006.01.012","volume":"245","author":"D Kostrzewa-Nowak","year":"2007","unstructured":"Kostrzewa-Nowak D et al (2007) Bioreductive activation of mitoxantrone by NADPH cytochrome P-450 reductase. Implications for increasing its ability to inhibit the growth of sensitive and multidrug resistant leukaemia HL60 cells. Cancer Lett 245(1\u20132):252\u2013262","journal-title":"Cancer Lett"},{"issue":"2","key":"1040_CR19","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0009-2797(94)03603-6","volume":"97","author":"SJ Li","year":"1995","unstructured":"Li SJ, Rodgers EH, Grant MH (1995) The activity of xenobiotic enzymes and the cytotoxicity of mitoxantrone in MCF 7 human breast cancer cells treated with inducing agents. Chem Biol Interact 97(2):101\u2013118","journal-title":"Chem Biol Interact"},{"key":"1040_CR20","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","volume":"193","author":"OH Lowry","year":"1951","unstructured":"Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the folin phenol reagent, J Biol Chem (193):265\u2013272","journal-title":"J Biol Chem"},{"issue":"21","key":"1040_CR21","first-page":"5135","volume":"53","author":"K Mewes","year":"1993","unstructured":"Mewes K et al (1993) Cytochrome P-450-induced cytotoxicity of mitoxantrone by formation of electrophilic intermediates. Cancer Res 53(21):5135\u20135142","journal-title":"Cancer Res"},{"issue":"1\u20132","key":"1040_CR22","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.pharmthera.2005.07.002","volume":"109","author":"O Neuhaus","year":"2006","unstructured":"Neuhaus O, Kieseier BC, Hartung H-P (2006) Therapeutic role of mitoxantrone in multiple sclerosis. Pharmacol Ther 109(1\u20132):198\u2013209","journal-title":"Pharmacol Ther"},{"issue":"2","key":"1040_CR23","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/BF00174155","volume":"3","author":"RF Novak","year":"1985","unstructured":"Novak RF, Kharasch ED (1985) Mitoxantrone: propensity for free radical formation and lipid peroxidation-implications for cardiotoxicity. Invest New Drugs 3(2):95\u201399","journal-title":"Invest New Drugs"},{"issue":"1\u20132","key":"1040_CR24","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0304-3835(97)04611-9","volume":"113","author":"C Panousis","year":"1997","unstructured":"Panousis C, Kettle AJ, Phillips DR (1997) Neutrophil-mediated activation of mitoxantrone to metabolites which form adducts with DNA. Cancer Lett 113(1\u20132):173\u2013178","journal-title":"Cancer Lett"},{"key":"1040_CR25","first-page":"1331","volume-title":"Casarett & Doull\u2019s toxicology: the basic science of poisons","author":"A Parkinson","year":"2008","unstructured":"Parkinson A, Ogilvie B (2008) Biotransformation of xenobiotics. In: Klaassen C (ed) Casarett & Doull\u2019s toxicology: the basic science of poisons. McGraw-Hill, New York, p 1331"},{"issue":"2\u20133","key":"1040_CR26","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.tox.2010.02.010","volume":"270","author":"H Pontes","year":"2010","unstructured":"Pontes H et al (2010) Metabolic interactions between ethanol and MDMA in primary cultured rat hepatocytes. Toxicology 270(2\u20133):150\u2013157","journal-title":"Toxicology"},{"issue":"2","key":"1040_CR27","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0006-2952(91)90484-M","volume":"41","author":"B Richard","year":"1991","unstructured":"Richard B et al (1991) Interspecies variability in mitoxantrone metabolism using primary cultures of hepatocytes isolated from rat, rabbit and humans. Biochem Pharmacol 41(2):255\u2013262","journal-title":"Biochem Pharmacol"},{"issue":"8","key":"1040_CR28","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1007\/s00204-010-0630-9","volume":"85","author":"LG Rossato","year":"2011","unstructured":"Rossato LG et al (2011) Structural isomerization of synephrine influences its uptake and ensuing glutathione depletion in rat-isolated cardiomyocytes. Arch Toxicol 85(8):929\u2013939","journal-title":"Arch Toxicol"},{"issue":"4","key":"1040_CR29","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s00280-009-0932-x","volume":"64","author":"V Sard\u00e3o","year":"2009","unstructured":"Sard\u00e3o V et al (2009a) Doxorubicin-induced mitochondrial dysfunction is secondary to nuclear p53 activation in H9c2 cardiomyoblasts. Cancer Chemother Pharmacol 64(4):811\u2013827","journal-title":"Cancer Chemother Pharmacol"},{"issue":"3","key":"1040_CR30","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s10565-008-9070-1","volume":"25","author":"V Sard\u00e3o","year":"2009","unstructured":"Sard\u00e3o V et al (2009b) Morphological alterations induced by doxorubicin on H9c2 myoblasts: nuclear, mitochondrial, and cytoskeletal targets. Cell Biol Toxicol 25(3):227\u2013243","journal-title":"Cell Biol Toxicol"},{"issue":"2","key":"1040_CR31","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1517\/14740338.4.2.219","volume":"4","author":"K Seiter","year":"2005","unstructured":"Seiter K (2005) Toxicity of the topoisomerase II inhibitors. Expert Opin Drug Saf 4(2):219\u2013234","journal-title":"Expert Opin Drug Saf"},{"issue":"3","key":"1040_CR32","first-page":"550","volume":"53","author":"NG Shipp","year":"1993","unstructured":"Shipp NG et al (1993) Characterization of experimental mitoxantrone cardiotoxicity and its partial inhibition by ICRF-187 in cultured neonatal rat heart cells. Cancer Res 53(3):550\u2013556","journal-title":"Cancer Res"},{"issue":"4","key":"1040_CR33","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s00204-010-0587-8","volume":"85","author":"R Silva","year":"2011","unstructured":"Silva R et al (2011) In vitro study of P-glycoprotein induction as an antidotal pathway to prevent cytotoxicity in Caco-2 cells. Arch Toxicol 85(4):315\u2013326","journal-title":"Arch Toxicol"},{"issue":"9","key":"1040_CR34","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/0006-2952(86)90127-9","volume":"35","author":"CR Wolf","year":"1986","unstructured":"Wolf CR, Macpherson JS, Smyth JF (1986) Evidence for the metabolism of mitozantrone by microsomal glutathione transferases and 3-methylcholanthrene-inducible glucuronosyl transferases. Biochem Pharmacol 35(9):1577\u20131581","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"1040_CR35","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1093\/toxsci\/62.2.221","volume":"62","author":"S Yoshihara","year":"2001","unstructured":"Yoshihara S et al (2001) Metabolic activation of bisphenol A by rat liver S9 fraction. Toxicol Sci 62(2):221\u2013227","journal-title":"Toxicol Sci"},{"issue":"3","key":"1040_CR36","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.vascn.2007.06.001","volume":"56","author":"BNM Zordoky","year":"2007","unstructured":"Zordoky BNM, El-Kadi AOS (2007) H9c2 cell line is a valuable in vitro model to study the drug metabolizing enzymes in the heart. J Pharmacol Toxicol Methods 56(3):317\u2013322","journal-title":"J Pharmacol Toxicol Methods"}],"container-title":["Archives of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-013-1040-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00204-013-1040-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-013-1040-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,12]],"date-time":"2022-02-12T19:26:16Z","timestamp":1644693976000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00204-013-1040-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,2]]},"references-count":36,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["1040"],"URL":"https:\/\/doi.org\/10.1007\/s00204-013-1040-6","relation":{},"ISSN":["0340-5761","1432-0738"],"issn-type":[{"value":"0340-5761","type":"print"},{"value":"1432-0738","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,2]]}}}